Cambridge, MA
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.
clasptx.com/homeThese are collections Clasp Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$150,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Clasp Therapeutics.